| Name | Title | Contact Details |
|---|
Nexient is America’s largest 100% US-based software services partner, helping clients outpace their competition through Agile development and Product-minded innovation.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Locl is a location performance software that helps businesses gain new insights on their clients for better decisions and tune out the BS. It allows businesses to connect visitors to destinations and customers to businesses with Locl’s expertise.
TekVista is a Fremont, CA-based company in the Software and Internet sector.
Unfold is a toolkit for storytellers that provides beautiful and engaging templates for creating stories, reels, and posts. They also offer Unfold Pro, an all-in-one government relations platform that simplifies legislative research and outreach.